183991-46-0

Basic information

• Product Name: N-formyl-N-benzyloxyamine
• Synonyms: N-formyl-N-benzyloxyamine
• CAS NO: 183991-46-0
• Molecular Weight: 151.165
• Mol File: 183991-46-0.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: N-formyl-N-benzyloxyamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-formyl-N-benzyloxyamine(183991-46-0)
• EPA Substance Registry System: N-formyl-N-benzyloxyamine(183991-46-0)

Safety Data

• Hazardous Substances Data: 183991-46-0(Hazardous Substances Data)

Upstream product

• 622-33-3 N-benzyloxyamine 
• 109-94-4 formic acid ethyl ester 
• 64-18-6 formic acid 
• 2687-43-6 O-benzylhydoxylamine hydrochloride 

Downstream Products

• 669091-40-1 7-(benzyloxy-formyl-amino)-2-tert-butoxycarbonylamino-heptanoic acid 2-trimethylsilanyl-ethyl ester 
• 1029325-06-1 N-(benzyloxy)-N-(hydroxymethyl)formamide 
• 1233976-69-6 ethyl 2-{[N-(benzyloxy)formamido]methyl}hexanoate 

Relevant articles and documents

Synthesis of new sulfonyloximes and their use in free-radical olefin carbo-oximation

New bifunctional reagents for free-radical carbo-oximation of olefins have been developed. In this process, a single reagent can act both as a trap for nucleophilic radicals as well as a source of electrophilic radical via an α-scission of an alkylsulfonyl radical. This strategy involving the addition of a C-centered electrophilic radical and an oxime across the double bond of an electron-rich alkene is initiated with a t-BuO radical following an unusual mechanism, supported by both experiments and density functional theory calculations.

GONADOTROPIN RELEASING HORMONE RECEPTOR ANTAGONISTS, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

The present invention provides gonadotropin releasing hormone receptor antagonists and the pharmaceutical composition comprising the same, which can be useful in preventing or treating a sex hormone-related disease such as endometriosis, amenorrhea, irregular menstruation, uterine myoma, uterine fibroids, polycystic ovarian disease, lupus erythematous, hypertrichosis, precocious puberty, short stature, acne, alopecia, gonadal steroid-dependent neoplasms, gonadotropin-producing pituitary adenoma, sleep apnea, irritable bowel syndrome, premenstrual syndrome, benign prostatic hyperplasia, contraception, and infertility, as well as Alzheimer disease

Synthesis and antimicrobial activities of novel peptide deformylase inhibitors

A new series of N-formylhydroxylamine compounds were designed, optimized with the AutoDock 4.0.1to investigate the interactions between the target compounds and the amino acid residues of the Escherichia coli PDF?Ni enzyme, and then synthesized through mu